77 related articles for article (PubMed ID: 27847545)
1. Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.
Thiboutot DM; Kircik L; McMichael A; Cook-Bolden FE; Tyring SK; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
J Clin Aesthet Dermatol; 2016 Oct; 9(10):18-27. PubMed ID: 27847545
[No Abstract] [Full Text] [Related]
2. Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.
Kircik LH; Stein Gold L; Gold M; Weiss JS; Harper JC; Del Rosso JQ; Bunick CG; Bhatia N; Tanghetti EA; Eichenfield LF; Baldwin H; Draelos ZD; Callender VD; Han G; Gooderham MJ; Sadick N; Lupo MP; Lain ET; Werschler WP
Dermatol Ther (Heidelb); 2024 May; 14(5):1211-1227. PubMed ID: 38724841
[TBL] [Abstract][Full Text] [Related]
3. An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color.
El-Kashlan N; Cices A; Kaufman B; Da Rosa JC; Sanabria-Gonzalez I; Khattri S; Alexis A
J Drugs Dermatol; 2024 Jun; 23(6):410-417. PubMed ID: 38834229
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Moderate-to-severe Acne Vulgaris in a Hispanic Population: A
Alexis AF; Cook-Bolden F; Lin T
J Clin Aesthet Dermatol; 2017 Jun; 10(6):36-43. PubMed ID: 28979655
[No Abstract] [Full Text] [Related]
5. Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
Schleicher S; Moore A; Rafal E; Gagne-Henley A; Johnson SM; Dhawan S; Chavda R; York JP; Sforzolini B; Holcomb K; Ablon G; Del Rosso J; Dreno B
Dermatol Ther (Heidelb); 2023 Dec; 13(12):3085-3096. PubMed ID: 37838987
[TBL] [Abstract][Full Text] [Related]
6. DMT310, a novel once-weekly topical treatment for patients with moderate-to-severe acne vulgaris: Results of a phase 2b randomized, double-blind, placebo-controlled trial.
Eichenfield LF; DuBois JC; Gold MH; Nardo CJ; Draelos ZD;
J Am Acad Dermatol; 2023 Nov; 89(5):945-951. PubMed ID: 37295506
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-centre, randomized, double-blind, vehicle-controlled study.
Le Y; Yang W; Lu J; Jiang X; Guo Q; Huang C; Sun Q; Wang H; Bi M; Wang H; Geng S; Yang B; Xu AE; Cui Y; Man X; Zhao Y; Zhang L; Li L; Song Z; Chen J; Cheng H; Zhu W; Han X; Li S; Lin T; Zhang C; Li J; Li Y; Ding Y; Wang L; Zhu Y; Xiang L
J Eur Acad Dermatol Venereol; 2024 Jul; ():. PubMed ID: 38948962
[TBL] [Abstract][Full Text] [Related]
8. Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of Acne.
Tan J; Draelos ZD; Gooderham MJ; Alexis AF; Graber E; Keri J; Woolery-Lloyd HC; Harper JC; Cook-Bolden FE; Konda A; Tanghetti EA
J Clin Aesthet Dermatol; 2023 Sep; 16(9):42-45. PubMed ID: 37720201
[TBL] [Abstract][Full Text] [Related]
9. Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial.
Bhavsar B; Choksi B; Sanmukhani J; Dogra A; Haq R; Mehta S; Mukherjee S; Subramanian V; Sheikh S; Mittal R
J Clin Diagn Res; 2014 Aug; 8(8):YC05-9. PubMed ID: 25302253
[TBL] [Abstract][Full Text] [Related]
10. A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris.
Shah B; Mistry D; Gonsalves N; Vasani P; Dhoot D; Barkate H
Antibiotics (Basel); 2023 Sep; 12(9):. PubMed ID: 37760751
[TBL] [Abstract][Full Text] [Related]
11. A Seven-week, Open-label Trial Evaluating the Safety and Efficacy of a Photopneumatic Device for Mitigating Mild-to-Moderate Acne in Healthy Adolescents and Young Adults.
Ablon G
J Clin Aesthet Dermatol; 2024 Jun; 17(6):13-20. PubMed ID: 38912192
[TBL] [Abstract][Full Text] [Related]
12. Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris.
Shucheng H; Zhou X; Du D; Li J; Yu C; Jiang X
Dermatol Ther (Heidelb); 2024 May; 14(5):1293-1314. PubMed ID: 38734843
[TBL] [Abstract][Full Text] [Related]
13. A Randomized, Double-Blind, Placebo-Controlled, Multicentric Study to Evaluate the Efficacy and the Tolerability of a Class II Medical Device in the Treatment of Mild and Moderate Acne.
Fabbrocini G; Ferrillo M; Donnarumma M; Papale A; Pinto D; Rinaldi F
Dermatol Ther (Heidelb); 2022 Aug; 12(8):1835-1845. PubMed ID: 35861908
[TBL] [Abstract][Full Text] [Related]
14. An innovative approach to the topical treatment of acne.
Sparavigna A; Tenconi B; De Ponti I; La Penna L
Clin Cosmet Investig Dermatol; 2015; 8():179-85. PubMed ID: 25914552
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Topical Dapsone 5% Gel for the Treatment of Erythematotelangiectatic Rosacea: New Treatment Option With Old Drug.
Gökşin Ş; İmren IG; Kaçar N
Dermatol Pract Concept; 2024 Jan; 14(1):. PubMed ID: 38364435
[TBL] [Abstract][Full Text] [Related]
16. Clinical Efficacy of Self-applied Blue Light Therapy for Mild-to-Moderate Facial Acne.
Gold MH; Andriessen A; Biron J; Andriessen H
J Clin Aesthet Dermatol; 2009 Mar; 2(3):44-50. PubMed ID: 20729943
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a deep cleansing gel in the management of mild to moderate facial acne.
Towersey L; Correia P; Feiges MF; Kerob D
J Cosmet Dermatol; 2024 Apr; ():. PubMed ID: 38622993
[No Abstract] [Full Text] [Related]
18. Dapsone 7.5% Gel: A Review in Acne Vulgaris.
Al-Salama ZT; Deeks ED
Am J Clin Dermatol; 2017 Feb; 18(1):139-145. PubMed ID: 28005194
[TBL] [Abstract][Full Text] [Related]
19. Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
Draelos ZD; Rodriguez DA; Kempers SE; Bruce S; Peredo MI; Downie J; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A
J Drugs Dermatol; 2017 Jun; 16(6):591-598. PubMed ID: 28686777
[TBL] [Abstract][Full Text] [Related]
20. Azelaic acid 20 % cream: effects on quality of life and disease severity in adult female acne patients.
Kainz JT; Berghammer G; Auer-Grumbach P; Lackner V; Perl-Convalexius S; Popa R; Wolfesberger B
J Dtsch Dermatol Ges; 2016 Dec; 14(12):1249-1259. PubMed ID: 27897372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
